<DOC>
	<DOCNO>NCT03102437</DOCNO>
	<brief_summary>This multicenter , prospective , single-arm Continued Access study Optimizer Smart System CCM therapy .</brief_summary>
	<brief_title>Continued Access Protocol Evaluation OPTIMIZER Smart System</brief_title>
	<detailed_description>The Continued Access study prospective , non-randomized , multi-center study design allow controlled access Optimizer Smart System PMA order issue FDA .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>1 . Subjects 18 year age old 2 . Subjects baseline ejection fraction great equal 25 % less equal 45 % echocardiography . 3 . Subjects , opinion Investigator ( base current guideline clinical practice ) , treat heart failure least 90 day currently receive appropriate , stable medical therapy 30 day prior enrollment treatment heart failure . 4 . Subjects New York Heart Association functional Class III IV time enrollment . 5 . Subjects willing able return followup visit . 1 . Subjects potentially correctible cause heart failure , valvular heart disease congenital heart disease . 2 . Subjects receive form inotropic support within 30 day enrollment , include subject continuous IV inotrope therapy . 3 . Subjects hospitalize decompensated heart failure require acute treatment intravenous loop diuretic , IV inotropes hemofiltration within 30 day enrollment baseline testing . 4 . Subjects PR interval great 375ms . 5 . Subjects schedule CABG PTCA procedure , undergone CABG procedure within 90 day PTCA procedure within 30 day enrollment . 6 . Subjects biventricular pacing system , accept indication device , QRS width 130ms great . 7 . Subjects myocardial infarction within 90 day enrollment . 8 . Subjects mechanical tricuspid valve . 9 . Subjects Left Ventricular Assist Device prior heart transplant . 10 . Subjects dialysis . 11 . Subjects participate another experimental protocol . 12 . Subjects unable provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Cardiac Contractility Modulation</keyword>
	<keyword>CCM</keyword>
</DOC>